• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Mineralys Completes Enrollment in Lorundrostat Hypertension Trial

    GLOBENEWSWIRE

    Mineralys Therapeutics Completes Enrollment In Advance-HTN Trial

    GLOBENEWSWIRE

    Mineralys Presents Post-Hoc Analysis from Target-HTN Phase 2 of Lorundrostat

    GLOBENEWSWIRE

    Mineralys Announces Expansion of Planned Phase 2 Trial of Lorundrostat

    GLOBENEWSWIRE

    Mineralys Announces First Patient Dosed the ADVANCE-HTN Trial of Lorundrostat

    GLOBENEWSWIRE

    Mineralys Presents Positive Lorundrostat Results from Phase 2 Target-HTN Trial

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.